LCM
TMCI icon

Legato Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Legato Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-56,220
Closed -$472K – 625
2025
Q1 		$472K Buy
+56,220
New +$505K 0.06% 432
2023
Q3 		– Sell
-19,270
Closed -$493K – 645
2023
Q2 		$493K Buy
+19,270
New +$497K 0.07% 423
2023
Q1 		– Sell
-34,494
Closed -$793K – 531
2022
Q4 		$793K Buy
+34,494
New +$794K 0.15% 233

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legato Capital Management's TMCI Position: Q2 2025 in Review

Legato Capital Management sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 56,220 shares — an estimated $472K sold.

Legato Capital Management first reported a position in TMCI in Q4 2022 and held it in 3 quarters. The position peaked at $793K in Q4 2022. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • Legato Capital Management reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • Legato Capital Management sold 56,220 Treace Medical Concepts shares in Q2 2025, an estimated $472K.
  • Legato Capital Management first reported a position in Treace Medical Concepts in Q4 2022 and held it in 3 quarters.
  • Legato Capital Management's Treace Medical Concepts position peaked at $793K in Q4 2022.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on Legato Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.